CANTONI, CLAUDIA
 Distribuzione geografica
Continente #
EU - Europa 14.151
AS - Asia 8
SA - Sud America 7
NA - Nord America 1
Totale 14.167
Nazione #
IT - Italia 14.151
BR - Brasile 5
CN - Cina 3
SG - Singapore 3
VN - Vietnam 2
CL - Cile 1
EC - Ecuador 1
US - Stati Uniti d'America 1
Totale 14.167
Città #
Genova 9.136
Genoa 2.990
Rapallo 1.048
Vado Ligure 957
Bordighera 20
Singapore 3
Ambato 1
Ashburn 1
Cachoeiras de Macacu 1
Duque de Caxias 1
Ho Chi Minh City 1
Montes Claros 1
Ninh Bình 1
Peñalolén 1
Porto Alegre 1
São Gonçalo 1
Totale 14.164
Nome #
PVR(CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis 206
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27 192
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 190
Role of the calpain-calpastatin system in the density-dependent growth arrest 181
'Emergency exit' of bone-marrow-resident CD34+ DNAM-1 bright CXCR4+-committed lymphoid precursors during chronic infection and inflammation 174
A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. 174
A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation. 170
Effect of tumor cells and tumor microenvironment on NK-cell function. 169
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment 169
Involvement of exon 6-mediated calpastatin intracellular movements in the modulation of calpain activation. 167
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias 165
Characterization of the calpain/calpastatin system in human hemopoietic cell lines 165
M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages 159
Bispecific monoclonal antibodies directed to CD16 and to a tumor-associated antigen induce target-cell lysis by resting NK cells and by a subset of NK clones. 157
Pseudorabies Virus US3 Protein Kinase Protects Infected Cells from NK Cell-Mediated Lysis via Increased Binding of the Inhibitory NK Cell Receptor CD300a 157
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 156
NCR + ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures 155
Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression 155
CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells. 154
A novel type of GABA receptor in rat spinal cord? 154
Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor 153
NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines 153
Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. 153
Molecular structures of HLA-specific human NK cell receptors. 148
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 148
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs 147
Characterization of human afferent lymph dendritic cells from seroma fluids. 147
DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis 145
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. 145
Crystal structure of the extracellular domain of the human natural killer cell activating receptor NKp44 144
Induction of anti-tumor immune response by bispecific monoclonal antibodies (bimAbs). 142
Characterization of a cyclosporin A-sensitive activation pathway in cultured T and natural killer cells. 142
CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. 140
Expression of HLA-class I-specific inhibitory Natural Killer cell receptors in HIV-specific cytolytic T lymphocytes. Impairment of specific cytolytic functions. 139
HLA class-I-specific NK receptors belong to two distinct molecular families and display inhibitory or activating function. 139
DNAM-1 and PVR regulate monocyte migration through endothelial junctions 139
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis 136
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy? 136
null 135
P49, a putative HLA-G1 specific inhibitory NK receptor belonging to the immunoglobulin Superfamily. 134
Direct involvement of CD56 in cytokine-induced killer-mediated lysis of CD56+ hematopoietic target cells 133
Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing 131
Targeting CD44/xCT is a potential strategy to sensitize human neuroblastoma stem cells to etoposide 130
Expression of human NKRP1A by CD34+ immature thymocytes: NKRP1A-mediated regulation of proliferation and cytolytic activity. 128
The three-dimensional structure of NK cell receptor NKp44, a triggering partner in natural cytotoxicity 128
Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. 128
Effect of Melanoma-derived Fibroblasts on NK Cell Phenotype and Functions 128
Physical and functional association of CD45 and CD3-TCR complex on CD1+ human thymocytes. Evidence that the engagement of CD45 molecules can prevent CD1+ thymocytes from apoptosis. 127
Human NK Cells Induce Neutrophil Apoptosis via an NKp46- and Fas-Dependent Mechanism. 126
Modulation of CD112 by the alphaherpesvirus gD protein suppresses DNAM-1-dependent NK cell-mediated lysis of infected cells. 125
Identification of the rat homologue of the human NKp46 triggering receptor 125
Human natural killer cell function and receptors. 124
IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors 124
Reciprocal expression of CD70 and of its receptor, CD27, in human long term-activated T and natural killer (NK) cells: inverse regulation by cytokines and role in induction of cytotoxicity. 124
The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface Ligands 124
Phenotypic, functional and molecular analysis of CD3- LGL expansions indicates a relationship to two different CD3- normal counterparts. 124
Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin 123
Structural Insights into the Inhibitory Mechanism of an Antibody against B7-H6, a Stress-Induced Cellular Ligand for the Natural Killer Cell Receptor NKp30 123
The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function 121
Regulatory role of NKp44, NKp46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells. 120
Human natural killer cell activating receptors. 117
Role of NK cells in immunotherapy and virotherapy of solid tumors 117
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation 117
Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity. 117
p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily 116
null 116
Cutaneous T Cell Lymphoma Cells Express a Novel Allelic Form of the p140/Killer Cell Immunoglobulin-Like Receptor 115
Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences on the NK-mediated killing of dendritic cells 115
Human NK cells and their receptors 114
Human natural killer cell receptors: insights into their molecular function and structure 114
Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. 113
The Immune Inhibitory Receptor LAIR-1 Is Highly Expressed by Plasmacytoid Dendritic Cells and Acts Complementary with NKp44 to Control IFNα Production. 113
HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells 112
Human natural killer cell receptors and co-receptors. 112
Cultured human NK cells express the Ki-1/CD30 antigen. 110
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule 110
Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity 110
Pkcα inhibition as a strategy to sensitize neuroblastoma stem cells to etoposide by stimulating ferroptosis 110
Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. 108
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines. Regulation by KIR/HLA-class I interaction. 106
Human decidua contains NK cell committed CD34+ hematopoietic precursors able to differentiated into functional Natural Killer cells 106
Functional characterization of natural killer cells in type I leukocyte adhesion deficiency 106
Identification of 4Ig-B7-H3 as a novel neuroblastoma-associated molecule that exerts a protective role from natural killer cell-mediated lysis 105
Symptomatic carotid atherosclerotic plaques are associated with increased infiltration of natural killer (NK) cells and higher serum levels of NK activating receptor ligands 105
The corticosteroid-induced inhibitory effect on NK cell function reflects downregulation and/or disfunction of triggering receptors involved in natural cytotoxicity. 103
The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. 103
Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor 102
Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell lines. 102
NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. 101
The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. 100
Targeting of T or NK lymphocytes against tumor cells by bispecific monoclonal antibodies: role of different triggering molecules. 99
NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans 99
The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. 97
null 96
Identification, molecular cloning and functional characterization of NKp46 and NKp30 Natural Cytotoxicity Receptors in Macaca fascicularis (Macaca Rhesus) NK cells 95
MELANOMA CELLS INTERFERE WITH THE ACTIVITY OF NK CELLS BY MODULATING THEIR PHENOTYPE AND CYTOTOXIC FUNCTION 93
Selective cross-talk among natural cytotoxicity receptors in human natural killers cells 92
The innate immune cross talk between NK cells and eosinophils is regulated by the interaction of Natural Cytotoxicity Receptors with eosinophil surface ligands 92
Natural killer cells in pregnancy: how they may avoid their attack to fetal tissues 91
null 91
Totale 12.990
Categoria #
all - tutte 45.010
article - articoli 42.612
book - libri 0
conference - conferenze 1.766
curatela - curatele 0
other - altro 0
patent - brevetti 525
selected - selezionate 0
volume - volumi 107
Totale 90.020


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021701 0 0 0 83 45 95 48 78 83 101 91 77
2021/20221.419 59 111 132 170 60 75 75 334 54 121 68 160
2022/20231.265 126 81 14 145 205 244 0 86 195 4 152 13
2023/2024644 24 76 17 92 75 101 23 41 52 20 43 80
2024/20252.173 37 155 108 149 347 222 192 299 97 98 206 263
2025/2026967 416 96 231 224 0 0 0 0 0 0 0 0
Totale 14.408